Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
about
HPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsExpenditure and resource utilisation for cervical screening in Australia.Systematic review of model-based cervical screening evaluations.The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New ZealandOptimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaEffect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature.Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.The day we started HPV triage.Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H).Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.Diagnostic accuracy of colposcopy with dynamic spectral imaging for cytology-negative/high-risk HPV positive (failed test of cure) after large loop excision of the transformation zone (LLETZ) of the cervix: Results of the DySIS colposcopy 1 study.
P2860
Q26771420-299675E3-7983-4BBA-9E8C-D5E0CAD70CB4Q34502683-18876257-54CA-4B72-B45E-299A7FAFDC1AQ35568922-CF26C9D4-3959-48A9-A76B-B478311B8F3CQ35984769-1CCA891C-E943-426C-A877-AFA899CECBCEQ35998533-AECB3229-44B4-45B9-815A-FDCB15550C76Q36019886-4F438FF0-B930-46E1-AD66-4B5DB616957AQ36251151-497186BC-0C4F-4DFC-9BE5-0C58069B1C8AQ37503431-ED0046D3-E940-487A-A054-5CF2DEF3BCC0Q38602571-611844C8-EF93-4F49-AA37-8F5A1BE228C0Q40569845-F4D745A0-3FE8-47B9-A29B-9EAD81D49176Q40734948-B919579A-A1D4-4C61-98BD-4FC43F661D46Q40995859-F2852FBC-EA2B-40BA-9C22-9CA13E66A5B7Q42242703-A1DEEAAB-31C0-4EE3-9335-2470505B4A06Q50000948-94D84AC2-6ADF-477E-B8C7-A287A3FF6F82Q54262186-92DD8942-B7DB-4BF5-BFCE-322A0A0C4DC9
P2860
Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@ast
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@en
type
label
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@ast
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@en
prefLabel
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@ast
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@en
P2093
P2860
P356
P1433
P1476
Cost effectiveness of human pa ...... from NHS Sentinel Sites Study
@en
P2093
Henry Kitchener
Julietta Patnick
Karen Canfell
Robert Walker
Rosa Legood
P2860
P356
10.1136/BMJ.E7086
P407
P577
2012-10-31T00:00:00Z